Local inhibition of Rho signaling by cell-permeable recombinant protein BA-210 prevents secondary damage and promotes functional recovery following acute spinal cord injury

Journal of Neurotrauma

Volumn 25, Issue 11, 2008, Pages 1309-1322

  Lord Fontaine, Stephanie ^a   Yang, Fan ^a   Diep, Quy ^a   Dergham, Pauline ^a,b   Munzer, Scott ^a   Tremblay, Patrick ^a,c   McKerracher, Lisa ^a,b  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c NONE   (Canada)

Author keywords

Contusion; Neuroprotection; Regeneration; Rho GTPase; Spinal cord injury

Indexed keywords

BA210; EXOENZYME C3; FIBRIN GLUE; NEUROPROTECTIVE AGENT; RHO FACTOR; UNCLASSIFIED DRUG;

ACUTE DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CONVALESCENCE; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; DURA MATER; FEMALE; MALE; MOUSE; NONHUMAN; RAT; SPINAL CORD INJURY; THORACIC SPINAL CORD;

AMINO ACID SEQUENCE; ANIMALS; CELL MEMBRANE; DIFFUSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DURA MATER; ESCHERICHIA COLI; FEMALE; IMMUNOHISTOCHEMISTRY; INJECTIONS; LOCOMOTION; MALE; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PAIN MEASUREMENT; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; RECOVERY OF FUNCTION; RHO GTP-BINDING PROTEINS; SIGNAL TRANSDUCTION; SPINAL CORD INJURIES;

EID: 57349179914     PISSN: 08977151     EISSN: None     Source Type: Journal    
DOI: 10.1089/neu.2008.0613     Document Type: Article

References (49)

1. Adcock, K.H., Brown, D.J., Shearer, M.C., Shewan, D., Schachner, M., Smith, G.M., Geller, H.M., and Fawcett, J.W. (2004). Axon behavior at Schwann cell-astrocyte boundaries: manipulation of axon signalling pathways and the neural adhesion molecule L1 can enable axons to cross. Eur. J. Neurosci. 6, 1425-1435.
2. Ahmed, Z., Dent, R.G., Suggate, E.L., Barrett, L.B., Seabright, R.J., Berry, M., and Logan, A. (2005). Disinhibition of neurotrophin-induced dorsal root ganglion cell neurite outgrowth on CNS myelin by siRNA-mediated knockdown of NgR, p75NTR and Rho-A. Mol. Cell Neurosci. 28, 509-523.
3. Basso, D.M., Beattie, M.S., and Bresnahan, J.C. (1995). A sensitive and reliable locomotor rating scale for open filed testing in rats. J. Neurotrauma 12, 1-21.
4. Basso, D.M., Beattie, M.S., and Bresnahan, J.C. (1996). Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp. Neurol. 139, 244-256.
5. Basso, D.M. (2000). Neuroanatomical substrates of functional recovery after experimental SCI: implications of basic science research for human spinal cord injury. Phys. Ther. 80, 808-817.
6. Bertrand, J., Winton, M.J., Rodriguez-Hernandez, N., Campenot, R.B., and McKerracher, L. (2005). Application of Rho antagonist to neuronal cell bodies promotes neurite growth in compartmented cultures and regeneration of retinal ganglion cell axons in the optic nerve of adult rats. J. Neurosci. 25, 1113-1121.
7. Bertrand, J., Di Polo, A., and McKerracher, L. (2006). Enhanced survival and regeneration of axotomized retinal neurons by repeated delivery of cell-permeable C3-like Rho antagonists. Neurobiol. Dis. 25, 65-72.
8. Brabeck, C., Beschorner, R., Conrad, S., Mittelbronn, M., Bekure, K., Meyermann, R., Schluesener, H.J., and Schwab, J.M. (2004). Lesional expression of RhoA and RhoB following traumatic brain injury in humans. J. Neurotrauma 21, 697-706.
9. Conrad, S., Schluesener, H.J., Trautmann, K., Joannin, N., Meyermann, R., and Schwab, J.M. (2005). Prolonged lesional expression of RhoA and RhoB following spinal cord injury. J. Comp. Neurol. 487, 166-175.
10. Constantini, S., and Young, W. (1994). The effects of methylprednisolone and the ganglioside GM1 on acute spinal cord injury in rats. J. Neurosurg. 80, 97 11.
11. Dergham, P., Ellezam, B., Essagian, C., Avedissian, H., Lubell, W.D., and McKerracher, L. (2002). Rho signaling pathway targeted to promote spinal cord repair. J. Neurosci. 22, 6570-6577.
12. Dubreuil, C.I., Winton, M.J., and McKerracher, L. (2003). Rho activation patterns after spinal cord injury and the role of activated Rho in apoptosis in the central nervous system. J. Cell Biol. 162, 233-243.
13. Dubreuil, C.I., Marklund, N., Deschamps, K., McIntosh, T.K., and McKerracher, L. (2006). Activation of Rho after traumatic brain injury and seizure in rats. Exp. Neurol. 198, 361-369.
14. Figueroa, D.J., Benton, R.L., Velazquez, I., Torrado, A.I., Ortiz, C.M., Hernandez, C.M., Diaz, J.J., Magnuson, D.S., Whittemore, S.R., and Miranda, J.D. (2006). Inhibition of EphA7 up-regulation after spinal cord injury reduces apoptosis and promotes locomotor recovery. J. Neurosci. Res. 84, 1438-1451.
15. Fischer, D., Petkova, V., Thanos, S., and Benowitz, L.I. (2004). Switching mature retinal ganglion cells to a robust growth state in vivo: gene expression and synergy with RhoA inactivation. J. Neurosci. 24, 8726-8740.
16. Fournier, A.E., Takizawa, B.T., and Strittmatter, S.M. (2003). Rho kinase inhibition enhances axonal regeneration in the injured CNS. J. Neurosci. 23, 1416-1423.
17. Genth, H., Gerhard, R., Maeda, A., Amano, M., Kaibuchi, K., Aktories, K., and Just, I. (2003). Entrapment of Rho ADP-ribosylated by Clostridium botulinum C3 exoenzyme in the Rho-guanine nucleotide dissociation inhibitor-1 complex. J. Biol. Chem. 278, 28523-28527.
18. Guest, J.D., Hesse, D., Schnell, L., Schwab, M.E., Bunge, M.B., and Bunge, R.P. (1997). Influence of IN-1 antibody and acidic FGF-fibrin glue on the response of injured corticospinal tract axons to human Schwann cell grafts. J. Neurosci. Res. 50, 888-905.
19. Gingras, K., Avedissian, H., Thouin, E., Boulanger, V., Essagian, C., McKerracher, L., and Lubell, W.D. (2004). Synthesis and evaluation of 4-(1-aminoalkyl)-N-(4-pyridyl) cyclohexanecarboxamides as Rho kinase inhibitors and neurite outgrowth promoters. Bioorg. Med. Chem. Lett. 14, 4931-4934.
20. Han, S., Arvai, A.S., Clancy, S.B., and Tainer, J.A. (2001). Crystal structure and novel recognition motif of rho ADP-ribosylating C3 exoenzyme from Clostridium botulinum: structural insights for recognition specificity and catalysis. J. Mol. Biol. 305, 95-107.
21. Hata, K., Fujitani, M., Yasuda, Y., Doya, H., Saito, T., Yamagishi, S., Mueller, B.K., and Yamashita, T. (2006). RGMa inhibition promotes axonal growth and recovery after spinal cord injury. J. Cell Biol. 173, 47-58.
22. Kassam, A., Nemoto, E., Balzer, J., Rao, G., Welch, W.C., Kuwabara, H., Boada, F., and Horowitz, M. (2004). Effects of Tisseel fibrin glue on the central nervous system of nonhuman primates. Ear Nose Throat J. 83, 246-252.
23. Kubo, T., Endo, M., Hata, K., Taniguchi, J., Kitajo, K., Tomura, S., Yamaguchi, A., Mueller, B.K., and Yamashita, T. (2008). Myosin IIA is required for neurite outgrowth inhibition produced by repulsive guidance molecule. J. Neurochem. 105, 113-126.
24. Laufs, U., Endres, M., Stagliano, N., Amin-Hanjani, S., Chui, D.S., Yang, S.X., Simoncini, T., Yamada, M., Rabkin, E., Allen, P.G., Huang, P.L., Bohm, M., Schoen, F.J., Moskowitz, M.A., and Liao, J.K. (2000). Neuroprotection mediated by changes in the endothelial actin cytoskeleton. J. Clin. Invest. 106, 15-24.
25. Lasko, D., and McKerracher, L. (2006). Fluorescent assay of cell-permeable C3 transferase activity. Methods Enzymol. 406, 512-520.
26. Lehmann, M., Fournier, A., Selles-Navarro, I., Dergham, P., Sebok, A., Leclerc, N., Tigyi, G., and McKerracher, L. (1999). Inactivation of Rho signaling pathway promotes CNS axon regeneration. J. Neurosci. 19, 7537-7547.
27. Logan, A., Ahmed, Z., Baird, A., Gonzalez, A.M., and Berry, M. (2006). Neurotrophic factor synergy is required for neuronal survival and disinhibited axon regeneration after CNS injury. Brain 129, 490-502.
28. Macias, M.Y., Syring, M.B., Pizzi, M.A., Crowe, M.J., Alexanian, A.R., and Kurpad, S.N. (2006). Pain with no gain: allodynia following neural stem cell transplantation in spinal cord injury. Exp. Neurol. 201, 335-348.
29. Madura, T., Yamashita, T., Kubo, T., Fujitani, M., Hosokawa, K., and Tohyama, M. (2004). Activation of Rho in the injured axons following spinal cord injury. EMBO Rep. 5, 412-417.
30. McKerracher, L., and David, S. (2004). Easing the brakes on spinal cord repair. Nat. Med. 10, 1052-1053.
31. McKerracher, L., and Higuchi, H. (2006). Targeting Rho to stimulate repair after spinal cord injury. J. Neurotrauma 23, 309-317.
32. Monnier, P.P., Sierra, A., Schwab, J.M., Henke-Fahle, S., and Mueller, B.K. (2003). The Rho/ROCK pathway mediates neurite growth-inhibitory activity associated with the chondroitin sulfate proteoglycans of the CNS glial scar. Mol. Cell Neurosci. 22, 319-330.
33. Niederost, B., Oertle, T., Fritsche, J., McKinney, R.A., and Bandtlow, C.E. (2002). Nogo-A and myelin-associated glycoprotein mediate neurite growth inhibition by antagonistic regulation of RhoA and Rac1. J. Neurosci. 22, 10368-10376.
34. Nusser, N., Gosmanova, E., Makarova, N., Fujiwara, Y., Yang, L., Guo, F., Luo, Y., Zheng, Y., and Tigyi, G. (2006). Serine phosphorylation differentially affects RhoA binding to effectors: implications to NGF-induced neurite outgrowth. Cell Signal 18, 704-714.
35. Obata, K., and Noguchi, K. (2006). BDNF in sensory neurons and chronic pain. Neurosci. Res. 55, 1-10.
36. Ozdinler, P.H., and Erzurumlu, R.S. (2001). Regulation of neurotrophin-induced axonal responses via Rho GTPases. J. Comp. Neurol. 438, 377-387.
37. Ramer, L.M., Borisoff, J.F., and Ramer, M.S. (2004). Rho-kinase inhibition enhances axonal plasticity and attenuates cold hyperalgesia after dorsal rhizotomy. J. Neurosci. 24, 10796-10805.
38. Romero, M.I., Rangappa, N., Li, L., Lightfoot, E., Garry, M.G., and Smith, G.M. (2000). Extensive sprouting of sensory afferents and hyperalgesia induced by conditional expression of nerve growth factor in the adult spinal cord. J. Neurosci. 20, 4435-4445.
39. Rosenzweig, E.S., and McDonald, J.W. (2004). Rodent models for treatment of spinal cord injury: research trends and progress toward useful repair. Curr. Opin. Neurol. 17, 121-131.
40. Schwab, J.M., Conrad, S., Elbert, T., Trautmann, K., Meyermann, R., and Schluesener, H.J. (2004). Lesional RhoA+ cell numbers are suppressed by anti-inflammatory, cyclooxygenase-inhibiting treatment following subacute spinal cord injury. Glia 47, 377-386.
41. Schweigreiter, R., Walmsley, A.R., Niederost, B., Zimmermann, D.R., Oertle, T., Casademunt, E., Frentzel, S., Dechant, G., Mir, A., and Bandtlow, C.E. (2004). Versican V2 and the central inhibitory domain of Nogo-A inhibit neurite growth via p75NTR/NgR-independent pathways that converge at RhoA. Mol. Cell Neurosci. 27, 163-174.
42. Sekhon, L.H., and Fehlings, M.G. (2001). Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine 26, S2-12.
43. Sung, J.K., Miao, L., Calvert, J.W., Huang, L., Louis Harkey, H., and Zhang, J.H. (2003). A possible role of RhoA/Rho-kinase in experimental spinal cord injury in rat. Brain Res. 959, 29-38.
44. Thuret, S., Moon, L.D., and Gage, F.H. (2006). Therapeutic interventions after spinal cord injury. Nat. Rev. Neurosci. 7, 628-643.
45. Wahl, S., Barth, H., Ciossek, T., Aktories, K., and Mueller, B.K. (2000). Ephrin-A5 induces collapse of growth cones by activating Rho and Rho kinase. J. Cell Biol. 149, 263-270.
46. Winton, M.J., Dubreuil, C.I., Lasko, D., Leclerc, N., and McKerracher, L. (2002). Characterization of new cell-permeable C3-like proteins that inactivate Rho and stimulate neurite outgrowth on inhibitory substrates. J. Biol. Chem. 277, 32820 2829.
47. Yamagishi, S., Fujitani, M., Hata, K., Kitajo, K., Mimura, F., Abe, H., and Yamashita, T. (2005). Wallerian degeneration involves Rho/Rho-kinase signaling. J. Biol. Chem. 280, 20384-20388.
48. Yamashita, T., Fujitani, M., Yamagishi, S., Hata, K., and Mimura, F. (2005). Multiple signals regulate axon regeneration through the Nogo receptor complex. Mol. Neurobiol. 32, 105-111.
49. Zhang, Y.P., Iannotti, C., Shields, L.B., Han, Y., Burke, D.A., Xu, X.M., and Shields, C.B. (2004). Dural closure, cord approximation, and clot removal: enhancement of tissue sparing in a novel laceration spinal cord injury model. J. Neurosurg. 100, 343-352.